KRAS and colorectal carcinoma: For example, low plasma adiponectin levels are associated with KRAS-mutated, but not KRAS wild-type, CRC risk [14], and aspirin use is associated with BRAF-mutated, but not BRAF wild-type, CRC risk [15].